Gradient Investments LLC: EIX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Gradient Investments LLC on EIX, newest first. How the timeline and the estimate are built.
Gradient Investments LLC held 262,806 EIX shares at 2026-09-30 per its 13F-HR filed 2026-10-08.
the latest 13F is the newest step
- period ended2026-09-3013F 262,806 sharesChange vs previous 13F +11,523 shares
0.2% of the 13F portfolio, value $14,120,578.
13F-HR 0001542265-26-000006 filed by Gradient Investments LLC
Accepted , ingested - period ended2026-06-3013F 251,283 sharesChange vs previous 13F -1,322 shares
0.26% of the 13F portfolio, value $18,707,990.
13F-HR 0001542265-26-000005 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 252,605 sharesChange vs previous 13F -10,451 shares
0.29% of the 13F portfolio, value $18,485,610.
13F-HR 0001542265-26-000003 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 263,056 sharesChange vs previous 13F +237,999 shares
0.25% of the 13F portfolio, value $15,788,621.
13F-HR 0001542265-26-000001 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 25,057 sharesChange vs previous 13F -2,597 shares
0.02% of the 13F portfolio, value $1,385,151.
13F-HR 0001542265-25-000007 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 27,654 sharesChange vs previous 13F not available
0.03% of the 13F portfolio, value $1,426,946.
13F-HR 0001542265-25-000004 filed by Gradient Investments LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).